- •Ocular Blood Flow
- •Contents
- •1: Anatomy of the Ocular Vasculatures
- •Core Messages
- •1.1 Limbus and Conjunctiva
- •1.1.1 Cornea
- •1.1.2 Vasculature Distribution in the Anterior Segment
- •1.1.3 The Conjunctiva
- •1.1.3.1 The Conjunctival Arterial Supply
- •1.1.3.2 The Conjunctival Veins
- •1.2 Uveal Tract
- •1.2.1 The Iris
- •1.2.1.1 The Major Arterial Circle of the Iris
- •1.2.2 Ciliary Body and Processes
- •1.2.3 Choroid and Suprachoroid
- •1.2.3.1 Development of the Choroidal Vasculature
- •1.2.3.2 Arteries
- •1.2.3.3 Choroidal Veins (Vortex Veins)
- •1.2.3.4 Choriocapillaris
- •1.3 Optic Nerve Vasculature
- •1.4 Retina
- •1.4.1 Development of the Retinal Vasculature
- •1.4.2 Adult Retinal Vasculature
- •1.4.3 Nonprimate Adult Retinal Vasculatures
- •1.5 Conclusions
- •References
- •Core Messages
- •2.1 Introduction
- •2.3 Stochastic Error in the Entrapment of Microspheres
- •2.4 Methodological Errors and Practical Advice
- •2.4.1 Size of the Microspheres
- •2.4.2 Physical Characteristics of Microspheres
- •2.4.4 Dissection
- •2.4.5 Detection of RM and NAM
- •2.4.6 Detection of CM and FM
- •2.5 Biological Variation
- •2.5.1 Blood Pressure
- •2.5.3 Arterial Blood Gases
- •2.5.4 Other Possible Causes for Biological Variability
- •2.6 Summary for the Clinician
- •References
- •3: Laser Doppler Flowmetry in Animals
- •Core Messages
- •3.1 Introduction
- •3.2 History
- •3.3 Theory
- •3.4 Validation
- •3.5 Calibration
- •3.6 Zero Offset
- •3.7 Effects of Oxygen
- •3.9 Measurement Depth and Sampling Volume
- •3.10 Caveats
- •References
- •4: Oxygen Measurements in Animals
- •Core Messages
- •4.1 Introduction
- •4.2.1 Oxygen Electrodes
- •4.2.2 Hypoxyprobe
- •4.2.3 Magnetic Resonance Imaging
- •4.2.4 Phosphorescence Decay
- •4.2.5 Oximetry
- •4.3.1 Vitreal Oxygen
- •4.3.2 Intraretinal Oxygen
- •4.4 Oxygen in Avascular Retinas
- •4.5 Analysis of Retinal Oxygen Utilization
- •4.5.1 Fick Principle Analyses
- •4.5.4 Other Diffusion Models
- •4.6 Physiological Variations in Retinal Oxygen
- •4.6.1 Light
- •4.6.2 Hypoxia
- •4.6.3 Hyperoxia
- •4.6.4 Hypercapnia
- •4.7 Pathophysiology and Retinal Oxygen
- •4.7.1 Vascular Occlusion
- •4.7.2 Diabetes
- •4.7.3 Retinal Detachment
- •4.7.4 Retinal Degenerative Diseases
- •4.7.5 Retinopathy of Prematurity
- •4.8 Retinal Molecular Changes Related to Oxygen
- •4.9 Oxygen in the Optic Nerve Head
- •References
- •Core Messages
- •5.1 Measuring Technique
- •5.2 Normal Values
- •5.3 Retinal Pathologies
- •5.3.1 Diabetes Mellitus
- •5.3.2 Central Retinal Vein Occlusion
- •5.4 Summary
- •References
- •Core Messages
- •6.1 Introduction
- •6.1.1 Anatomy
- •6.3 Vessel Diameter Measurements Based on Photographic and Digitally Stored Images
- •6.3.1 Basics for Measurements on Stored Images
- •6.3.1.1 Measuring Principle
- •6.3.1.4 Problems and Measuring Errors
- •6.3.1.5 Physiological Variability of Vessel Diameter
- •6.3.2 Methods
- •6.3.2.2 Microdensitometry Based on Photographic Negatives
- •6.3.2.3 Measurements Based on Digital Images
- •6.4 Diameter Assessment for Blood Flow
- •6.4.1 Assessment of Flow by Use of Doppler Technique (CLBF)
- •6.5 Retinal Vessel Analysis
- •6.5.1 Basics of Retinal Vessel Analysis
- •6.5.2 Static Vessel Analysis
- •6.5.3 Results and Limits of Static Vessel Analysis
- •6.5.4 Results and Limits of Dynamic Vessel Analysis
- •6.5.4.1 Stimulation with Flicker Light
- •6.5.4.2 Other Provocation Tests
- •6.5.5 Systems Available for Dynamic Vessel Analysis
- •6.6 Further Perspectives
- •References
- •Core Messages
- •7.1 Introduction
- •7.2 Retinal Laser Doppler Velocimetry
- •7.2.1 The Doppler Effect
- •7.2.2 Electric Field Scattered by Singly Scattering Particles Moving in a Capillary Tube
- •7.2.5 Experimental Test of the Bidirectional LDV Technique
- •7.2.7 The DSPS for RBCs Moving in a Retinal Vessel
- •7.2.7.1 Multiple Scattering of Blood
- •7.2.7.2 DSPS from RBCs Flowing in a Glass Capillary Tube
- •7.2.7.3 DSPS from Human Retinal Vessels
- •7.2.7.4 Exploring the Scattering Process
- •7.2.9 Instrumentation
- •7.2.10 Blood Flow in Retinal Vessels
- •7.2.12 Limitations, Safety, and Future Directions of the LDV Technique
- •7.2.13 Physiologic and Clinical Applications (Brief Overview)
- •7.3.1 The DSPS for RBCs Moving in the Microvascular Bed of a Tissue
- •7.3.2 Hemodynamic Parameters Derived from the DSPS
- •7.3.3 Detection Scheme for Optic Nerve and Subfoveal Choroidal Blood Flow
- •7.3.4 Critical Questions Regarding the Application of LDF to Ocular Blood Flow
- •7.3.4.1 LDF Sample Volume
- •7.3.4.2 Linearity of LDF
- •7.3.4.3 Scattering Scheme
- •7.3.5 Reproducibility of LDF
- •7.3.6 Applications of LDF
- •7.4 Summary for the Clinician
- •References
- •8: Color Doppler Imaging
- •Core Messages
- •8.1 Principles
- •8.2 Instrumentation
- •8.3 Procedure
- •8.4 Outcome Variables
- •8.5 Reproducibility
- •8.6 Physiological and Pharmacological Stimuli
- •8.7 Results in Patients with Disease
- •8.8 Advantages and Limitations
- •References
- •9: Other Approaches
- •Core Messages
- •9.1 Blue Field Entoptic Technique
- •9.1.1 Laser Speckle Technique
- •9.1.2 Pulsatile Ocular Blood Flow
- •9.1.2.1 Laser Interferometry
- •References
- •10: Systemic Determinants
- •Core Messages
- •10.1 Introduction
- •10.1.1 Ocular and Systemic Blood Flow
- •10.2 Local Skin Cooling Effect
- •10.2.1 Choroidal Blood Flow
- •10.2.2 Retinal Blood Flow
- •10.3 Aerobic Exercise
- •10.3.1 Choroidal Blood Flow
- •10.3.2 Macular Blood Flow
- •10.3.3 Retinal Blood Flow
- •10.4 Neural Activation
- •10.4.1 Valsalva Maneuver
- •10.4.2 Nicotine
- •10.5 Blood Pressure Versus Ocular Perfusion Pressure
- •10.5.1 Increased Ocular Perfusion Pressure
- •10.5.1.1 Choroidal Blood Flow
- •10.5.2 Decreased Ocular Perfusion Pressure
- •10.5.2.1 Choroidal Blood Flow
- •10.5.2.2 Optic Nerve Head Blood Flow
- •10.5.3 Neural Retinal Function
- •10.6 Blood Gases
- •10.6.1 Hyperoxia and Blood Flow
- •10.6.3 Hypoxia and Pulsatile Choroidal Blood Flow
- •10.6.4 Hyperoxia, Hypercapnia, and Retinal Function
- •10.6.5 Hypoxia, Hyperoxia, and Retinal Function
- •10.7 Regional Choroidal Perfusion
- •10.7.1 Cones Versus Rods: Structure and Function
- •10.7.2 Choroidal Angioarchitecture
- •10.7.3 Dark Adaptation
- •10.7.4 Protracted Blue Flicker
- •10.8 Aging
- •10.8.1 Structure
- •10.8.2 Blood Flow
- •10.8.3 Retinal Function
- •References
- •11: Local Determinants
- •Core Messages
- •11.1 Introduction
- •11.2 Ocular Perfusion Pressure, IOP, and the Ocular Starling Resistor Effect
- •11.3 Types of Local Control
- •11.3.1 Myogenic Local Control
- •11.3.2 Metabolic Local Control
- •11.3.3 Flow-Mediated Vasodilation
- •11.3.4 Flow Control by Intercellular Conduction
- •11.4 Ocular Local Control
- •11.4.1 Optic Nerve Head (ONH)
- •11.4.2 Choroid
- •11.4.3 Retina
- •11.4.4 Ciliary Body
- •11.4.5 Iris
- •11.5 Caveats
- •11.6 Summary for the Clinician
- •References
- •12: Neural Control of Ocular Blood Flow
- •Core Messages
- •12.1 Overview of Ocular Blood Supplies and Their Neural Control
- •12.2 Neural Control of Optic Nerve and Retinal Blood Flow
- •12.3 Neural Control of Iridial and Ciliary Body Blood Flow
- •12.4 Neural Control of Blood Flow in Orbital Glands
- •12.5 Neural Control of Choroidal Blood Flow
- •12.5.1 Importance of the Choroid
- •12.5.2 Choroidal Innervation: Overview of Anatomy
- •12.5.3 Facial Nucleus Parasympathetic Input
- •12.5.3.4 Choroidal Autoregulation and the PPG Input to Choroid – Mammals
- •12.5.3.8 Choroidal Autoregulation and the PPG Input to Choroid – Birds
- •12.5.4 Oculomotor Nucleus Parasympathetic Input
- •12.5.4.1 Ciliary Ganglion Circuitry – Mammals
- •12.5.4.2 Function of the EW-Ciliary Ganglion Circuit – Mammals
- •12.5.4.3 Ciliary Ganglion Circuitry – Birds
- •12.5.4.4 Function of vSCN-EWM-Ciliary Ganglion Circuit – Birds
- •12.5.5 Sympathetic Superior Cervical Ganglion Input
- •12.5.6 Trigeminal Sensory Input
- •12.5.7 Intrinsic Choroidal Neurons
- •12.5.8 Disturbed Neural Control of Choroidal Blood Flow in Aging and Retinal Disease
- •12.5.8.1 Effect of Aging on Retina and Choroid
- •12.5.8.2 Effect of Disease on Retina and Choroid
- •References
- •13: Endothelial and Adrenergic Control
- •Core Messages
- •13.1 Nitric Oxide
- •13.2 Endothelins
- •13.3 Arachidonic Acid Metabolites
- •13.4 Adrenergic Control
- •13.5 Alpha Receptors
- •13.6 Topical Administration
- •13.6.1 Clonidine
- •13.6.2 Brimonidine
- •13.6.3 Beta Receptors
- •13.6.4 Timolol
- •13.6.5 Human Studies
- •13.6.6 Betaxolol
- •13.6.7 Human Studies
- •13.6.8 Levobunolol
- •13.6.9 Carteolol
- •13.6.10 Serotonin
- •13.7 Carbonic Anhydrase Inhibitors
- •13.8 Acetazolamide
- •13.9 Dorzolamide
- •13.10 Retrobulbar Blood Flow
- •13.11 Retinal Blood Flow
- •13.12 Choroidal and Optic Nerve Head Blood Flow
- •13.13 Brinzolamide
- •References
- •Core Messages
- •14.1 Introduction
- •14.2 Retinal Ischemia Basic Mechanisms
- •14.3 Oxidative Stress
- •14.6 Animal Studies Relating Ischemia, Glaucoma, and Neuroprotection
- •14.6.1 Retinal Ischemia
- •14.6.6 Role of Mitochondria (Fig. 14.6)
- •References
- •Core Messages
- •15.1 Introduction
- •15.2 Retinal Blood Flow in Diabetes
- •15.3 Retinal Hypoperfusion
- •15.3.1 Mechanisms of Hypoperfusion
- •15.3.1.1 Glycaemic Control
- •15.3.1.2 Protein Kinase C
- •15.3.1.3 Ion Channel Dysfunction
- •15.4 Retinal Hyperperfusion
- •15.4.1 Mechanisms of Hyperperfusion: A Link to Hypoperfusion, Tissue Hypoxia and Retinal Leukostasis?
- •15.4.2 Retinal Autoregulation in Diabetes
- •15.5.1 Basement Membrane Thickening
- •15.5.3 Microaneurysms
- •15.5.4 Capillary Acellularity
- •15.6 Retinal Blood Flow and Vision Loss in Diabetic Retinopathy
- •15.6.1 Diabetic Macular Oedema
- •15.6.2 Proliferative Diabetic Retinopathy
- •15.7 Conclusions
- •15.8 Summary for the Clinician
- •References
- •Core Messages
- •16.1 Introduction
- •16.2 Choroidal Blood Flow
- •16.3 Systemic Vascular Factors and AMD
- •16.5 Choroidal Hemodynamic Changes in AMD
- •16.5.1 Choroidal Histopathological Vascular Changes in AMD
- •16.5.1.1 Choriocapillaris and Bruch’s Membrane in Aging and AMD
- •16.5.2 Choroidal Microcirculation in AMD
- •16.5.2.2 Choroidal Watershed Zones and Neovascularization
- •16.5.2.3 Laser Doppler Flowmetry Evaluation
- •References
- •Core Messages
- •17.1 Introduction
- •17.2 Potential Mechanisms of Ischaemic Damage in Glaucoma
- •17.2.2 Autoregulatory Disturbances
- •17.2.3 Mechanical Compression or Collapse of Vessels
- •17.2.4 Atherosclerosis
- •17.2.5 Vascular Endothelial Factors
- •17.2.6 Barriers to Nutrient Delivery
- •17.2.7 Circulating Vasoconstrictors
- •17.3 Evidence Base Supporting the Importance of Ischaemia in Glaucoma
- •17.3.1 Association and Causality
- •17.3.1.1 Reduction in Optic Nerve Head Blood Flow
- •17.3.1.2 Blood Pressure, Intraocular Pressure and Perfusion Pressure
- •17.3.1.3 Nocturnal Hypotension
- •17.3.1.4 Vasospasm
- •17.3.1.5 Endothelin and Other Circulating Peptides
- •17.3.2 Effects of Treatment
- •17.3.2.1 Calcium Channel Blockers
- •17.3.2.2 Topical Adrenergic Antagonists
- •17.3.2.4 Prostaglandin Analogues
- •17.4 Experimental Models of Ischaemia Relating to Glaucoma
- •17.4.1 Acute Ischaemia
- •17.4.2 Chronic Ischaemia
- •17.5 Summary
- •17.5.1 Diversity of Evidence
- •17.5.2 Evidence Base Compared to Intraocular Pressure
- •17.5.3 Requirements to Strengthen Evidence Base
- •References
- •Core Messages
- •18.1 Retinal Diseases
- •18.2 Uveitis
- •18.3 Optic Nerve Disorders
- •18.4 Systemic Diseases
- •References
- •Core Messages
- •19.1 Atherosclerosis
- •19.1.1 Pathogenesis of Atherosclerosis
- •19.1.2 Internal Carotid Artery Disease (ICA)
- •19.1.3 Effects on the Ocular Circulation
- •19.1.3.1 Retinal Artery Occlusion
- •Clinical Characteristics
- •Diagnosis
- •Mortality/Morbidity
- •19.1.3.2 Retinal Vein Occlusion (RVO)
- •Clinical Characteristics
- •Pathogenesis
- •Diagnosis
- •19.1.3.3 Ischemic Optic Neuropathy
- •Clinical Characteristics
- •Mortality/Morbidity
- •19.1.3.4 Asymptomatic Retinal Emboli
- •Background
- •Pathophysiology
- •19.2 Vasculitis
- •19.2.1 Takayasu’s Arteritis (Aortic Arch Syndrome)
- •19.2.1.1 Pathophysiology
- •19.2.1.2 Clinical Characteristics
- •19.2.1.3 Epidemiology
- •19.2.2 Behcet’s Disease
- •19.2.2.1 Clinical Characteristics
- •19.2.2.2 Pathogenesis
- •19.2.2.3 Diagnosis
- •19.2.2.4 Epidemiology
- •19.2.3 Thromboangiitis Obliterans
- •19.2.3.1 Diagnosis and Clinical Characteristics
- •19.2.3.2 Treatment
- •19.2.4 Temporal Arteritis
- •19.2.4.1 Epidemiology
- •19.2.4.2 Pathogenesis
- •19.2.4.3 Ocular Manifestations
- •19.2.5 Wegener’s Granulomatosis
- •19.2.5.1 Pathogenesis
- •19.2.5.2 Ocular Manifestation
- •19.2.5.3 Diagnosis
- •19.2.6 Kawasaki Disease
- •19.2.6.1 Clinical Characteristics
- •19.2.6.2 Diagnosis
- •19.3 Vascular Malformations
- •19.3.1.1 Diagnosis
- •19.3.1.2 Pathophysiology
- •19.4 Systemic Hypertension and Treatment
- •19.4.1 Etiology
- •19.4.1.1 Primary Hypertension
- •19.4.1.2 Secondary Hypertension
- •19.4.2 Pathophysiology
- •19.4.3 Pathology and Complications
- •19.4.4 Symptoms and Signs
- •19.4.5 Diagnosis of Hypertension
- •19.4.5.1 History
- •19.4.5.2 Physical Examination
- •19.4.5.3 Testing
- •19.4.6 Prognosis
- •19.4.7 General Treatment
- •19.4.7.2 Drugs
- •19.5 Hypertensive Retinopathy
- •19.5.2 Pathophysiology
- •19.5.3 Blood Pressure
- •19.5.3.1 The Risk of Stroke
- •19.5.3.2 The Risk of Coronary Heart Disease
- •19.5.4 Treatment
- •19.5.4.1 ACE Inhibitors and the Eye
- •References
- •Index
142 |
C.E. Riva |
|
|
Using two different stimuli, a pure red and a pure green illuminance ßicker, the coefÞcient of variation of the Flow responses was 26% (n = 5 trials) and 12% (n = 4).
The CVs of SFCH Vel, Vol, and Flow were reported to be 14%, 25%, and 18%, respectively, in subjects with AMD, and 8%, 18%, and 13%, respectively, in normal controls. No statistically signiÞcant differences were observed between these CVs for subjects with AMD and those for normal controls [83]. Another study in eyes with AMD of increasing severity provided a CV(Flow) of 10.3% ± 7.2% (n = 3 trials) [84].
With the confocal choroidal ßowmeter (Fig. 7.13), the sensitivity of SFCH Flow, calculated based on measurements in 10 subjects, was between 7.5% and 17.5% for Vel, 14.5Ð 37.8% for Vol, and 19.2Ð31.6% for the Flow [85]. Intrasubject variability was less than 8% for Vel and Vol and less than 18% for Flow, and the sensitivity of the measurements (21 subjects) was 3.3% for Vel, 7.1% for Vol, and 7.4% for Flow [86].
7.3.6Applications of LDF
Continuous, real-time LDF because of its high spatial and temporal resolution appears most suitable for the investigation of the regulatory processes of blood ßow in response to various physiological stimuli. The following investigations illustrate some of the applications. Regrettably, because of space limitation, it is not possible to mention all the important studies performed until now.
LDF investigations of ONH blood ßow in humans include the responses to: (1) changes in ocular perfusion pressure (increase and decrease) [75, 87, 88]; (2) hyperoxia, breathing carbogen, and mixtures of O2 and CO2 [89]; and (3) increased neuronal activity [90].
They also include a number of clinical studies, such as ONH blood ßow and its regulation in response to various stimuli in normal, ocular hypertensive, and glaucomatous eyes [91Ð97] and in children with cerebral malaria [98, 99].
LDF measurements of subfoveal choroidal blood ßow in humans are recent and include studies of the effect of (1) increases and decreases of ocular perfusion pressure [100Ð104]; (2) Valsalva maneuvers [105]; (3) breathing of various gas mixtures (pure O2, various mixtures of O2 and CO2) [86]; and (4) the effect of light [106Ð108]. Investigations of the effect of aging, age-related macular degeneration, and choroidal neovascularization have been reported [83, 84, 109Ð111].
7.4Summary for the Clinician
The LDV/LDF techniques have been applied over a number of years in normal subjects and patients with various ocular and systemic diseases. They provide a noninvasive means of investigating changes in blood ßow in the retina, ONH, and subfoveal choroid. Both techniques have a high sensitivity and a temporal response fast enough to reveal the changes in blood ßow during the cardiac cycle and in response to acute changes in various physiological stimuli. Their limitations include dilatation of the pupil, particularly for bidirectional LDV, good subject collaboration in terms of target Þxation, and head stability as well as clear media. These techniques open new avenues in the investigation of the regulation of blood ßow in the vascular tissues of the eye fundus in response to various physiological stimuli and the effect of a number of treatments on the ocular circulation.
Acknowledgement The author thanks the ÒFondazione Cassa di Risparmio in Bologna, ItalyÓ for its generous Þnancial support.
References
1.Shepherd AP (1990) History of laser-Doppler blood ßowmetry. In: Shepherd AP, …berg PA (eds) LaserDoppler blood ßowmetry. Kluwer Academic Publishers, Boston, pp 1Ð16
2. Riva CE, Ross B, Benedek GB (1972) Laser Doppler measurements of blood ßow in capillary tubes and retinal arteries. Invest Ophthalmol Vis Sci 11:936Ð944
7 Laser Doppler Techniques for Ocular Blood Velocity and Flow |
143 |
|
|
3. Tanaka T, Riva CE, Ben-Sira I (1974) Blood velocity measurements in human retinal vessels. Science 186:830Ð831
4. Stern MD (1975) In vivo evaluation of microcirculation by coherent light scattering. Nature 254:56Ð58
5. Riva CE, Grunwald JE, Sinclair SH (1982) Laser Doppler measurement of relative blood velocity in the human optic nerve head. Invest Ophthalmol Vis Sci 22:241Ð248
6. Riva CE, Harino S, Petrig BL, Shonat RD (1992) Laser Doppler ßowmetry in the optic nerve. Exp Eye Res 55:499Ð506
7. Riva CE, Falsini B, Geiser MH, Petrig BL (1999) Optice nerve head blood ßow response to ßicker: characteristics and possible mechanisms. In: Pillunat LE, Harris A, Anderson DR, Greve EL (eds) Current concepts on ocular blood ßow in glaucoma. Kugler Publications, The Hague, pp 191Ð196
8. Petrig BL, Riva CE (1999) Laser Doppler ßowmetry in the optic nerve head. Principle and technique. In: Pillunat LE, Harris A, Anderson DR, Greve EL (eds) Current concepts on ocular blood ßow in glaucoma. Kugler Publications, The Hague, pp 171Ð182
9. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL (1994) Choroidal blood ßow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci 35:4273Ð4281
10.Michelson G, Schmauss B, Langhans MJ, Harazny J, Groh MJM (1996) Principle, validity, and reliability of scanning laser Doppler ßowmetry. J Glaucoma 5:99Ð105
11.Riva CE, Petrig BL (1990) Retinal blood ßow: laser Doppler velocimetry and blue Þeld simulation technique. In: Masters BR (ed) Noninvasive diagnostic techniques in ophthalmology. Springer, New York,
pp390Ð409
12.Riva CE, Petrig BL (2003) Laser Doppler techniques in ophthalmology Ð Principles and applications. In: Fankhauser F, Kwasniewska S (eds) Lasers in ophthalmology Ð Basic, diagnostic and surgical aspects. Kugler Publications, The Hague, pp 51Ð59
13.Riva CE, Feke GT (1981) Laser Doppler velocimetry in the measurement of retinal blood ßow. In: Goldman L (ed) The biomedical laser technology and clinical applications. Springer, New York,
pp135Ð161
14.Riva CE, Petrig BL, Grunwald JE (1989) Retinal blood ßow. In: Shepherd AP, …berg PA (eds) Laser-Doppler blood ßowmetry. Kluwer Academic Publishers, Boston, pp 349Ð383
15.Benedek GB (1969) Optical mixing spectroscopy
with applications to problems in physics, chemistry, biology and engineering Polarization, Matter and Radiation (The Jubilee Volume in Honor of Alfred Kastler). Presses Universitaires de France, Paris,
pp49Ð84
16.Cummins HZ, Swinney HL (1970) Light beating spectroscopy. In: Wolf E (ed) Progress in optics. North-Holland Publishing Company, Amsterdam,
pp133Ð200
17.Riva CE, Feke GT, Eberli B, Benary V (1979) Bidirectional LDV system for absolute measurement of blood speed in retinal vessels. Appl Opt 18:2301Ð2306
18.Riva CE, Grunwald JE, Sinclair SH, OÕKeefe K (1981) Fundus camera based retinal LDV. Appl Opt 20:117Ð120
19. Feke GT, Goger DG, Tagawa H, Delori FC (1987) Laser Doppler technique for absolute measurement of blood speed in retinal vessels. IEEE Trans Biomed Eng BME-34:673Ð680
20. Garcia JPS Jr, Garcia PT, Rosen RB (2002) Retinal blood ßow in the normal human eye using the canon laser blood ßowmeter. Ophthalmic Res 34:295Ð299
21. Petrig BL, Follonier L (2005) Ray tracing model for the estimation of the power spectral properties in laser Doppler velocimetry of retinal vessels and its potential application to retinal vessel oximetry. Opt Express 13:10642Ð10651
22. Riva CE, Shonat RD, Petrig BL, Pournaras CJ (1989) Scattering process in LDV from retinal vessels. Appl Opt 28:1078Ð1083
23. Van de Hulst HC (1957) Light scattering by small particles. Wiley, New York
24. Feke GT, Riva CE (1978) Laser Doppler measurements of blood velocity in human retinal vessels. J Opt Soc Am 68:526Ð531
25.Riva CE, Grunwald JE, Petrig BL (1985) Laser Doppler measurement of retinal blood velocity: validity of the single scattering model. Appl Opt 24:605Ð607
26. Bonner R, Nossal R (1981) Model for laser Doppler measurements of blood ßow in tissue. Appl Opt 20:2097Ð2107
27.Stern MD (1985) Laser Doppler velocimetry in blood and multiply scattering ßuids: theory. Appl Opt 24: 1968Ð1983
28. Riva CE, Grunwald JE, Sinclair SH, Petrig BL (1985) Blood velocity and volumetric ßow rate in human retinal vessels. Invest Ophthalmol Vis Sci 26: 1124Ð1132
29.Petrig BL, Riva CE (1994) New continuous real-time analysis system for laser Doppler ßowmetry and velocimetry in the ocular fundus using a digital processor. In: Vision science and its application technical digest series. Optical Society of America, Washington, DC, pp 238Ð241
30.Petrig BL, Gehrig JP, Pompili P (2000) New multichannel DSP-based laser Doppler ßowmetry analysis system for quantiÞcation of ocular blood ßow. Proc SPIE 4156:318Ð327
31.Yoshida A, Feke GT, Mori F et al (2003) Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol 135:356Ð361
32. Logean E, Geiser MH, Petrig BL, Riva CE (1997) Portable ocular laser Doppler red blood cell velocimeter. Rev Sci Instrum 68:2878Ð2882
33.Riva CE, Petrig BL, Grunwald JE (1987) Nearinfrared retinal laser Doppler velocimetry. Lasers Ophthalmol 1:211Ð215
144 |
C.E. Riva |
|
|
34. Yoshida A, Feke GT, Feke GD, McMeel JW (1998) A new laser Doppler system for examining optic nerve head circulation. J Biomed Opt 3:396Ð400
35.Koller A, Kaley G (1991) Endothelial regulation of wall shear stress and blood ßow in skeletal muscle microcirculation. Am J Physiol 260:H862ÐH868
36.Nerem RM, Alexander RW, Chappell DC, Medford RM, Varner SE, Taylor WR (1998) The study of the inßuence of ßow on vascular endothelial biology. Am J Med Sci 316:169Ð175
37.Yazdanfar S, Rollins AM, Izatt JA (2000) Imaging and velocimetry of the human retinal circulation with color Doppler optical coherence tomography. Opt Lett 25:1448Ð1450
38.Leitgeb RA, Schmetterer L, Drexler W, Fercher AF (2003) Real-time assessment of retinal blood ßow with ultrafast acquisition by color Doppler Fourier domain optical coherence tomography. Opt Express 11:3116Ð3121
39.Ferguson RD, Hammer DX, Elsner AE, Webb RH, Burns SA, Weiter JJ (2004) Wide-Þeld retinal hemodynamic imaging with the tracking scanning laser ophthalmoscope. Opt Express 12:5198Ð5208
40.Bishop JJ, Nance PR, Popel AS, Intaglietta M, Johnson PC (2001) Effect of erythrocyte aggregation on velocity proÞles in venules. Am J Physiol Heart Circ Physiol 280:H222ÐH236
41.Logean E, Schmetterer L, Riva CE (2003) Velocity proÞle of red blood cells in human retinal vessels
using confocal scanning laser Doppler velocimetry. Laser Phys 13:45Ð51
42. Feke GT, Tagawa H, Deupree DM, Goger DG, Sebag J, Weiter JJ (1989) Blood ßow in the normal human retina. Invest Ophthalmol Vis Sci 30:58Ð65
43.Guan K, Hudson C, Flanagan JG (2003) Variability and repeatability of retinal blood ßow measurements using the canon Laser blood ßowmeter. Microvasc Res 65:145Ð151
44.Petrig BL, Riva CE (1988) Retinal laser-Doppler velocimetry: towards its computer assisted clinical use. Appl Opt 27:1126Ð1134
45.Delori FC, Pomerantzeff O, Mainster MA (1980) Light levels in ophthalmic diagnostic instruments. Proc SPIE 229:154Ð160
46.Delori FC, Webb RH, Sliney DH (2007) Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. J Opt Soc Am 24:1250Ð1265
47.Garhšfer G, Zawinka C, Resch H, Huemer KH, Dorner GT, Schmetterer L (2004) Diffuse luminance ßicker increase blood ßow in major retinal arteries and veins. Vision Res 44:833Ð838
48.Murray CD (1926) The physiological principle of minimum work. I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 12: 207Ð214
49.Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH (1986) Retinal blood ßow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 27:722Ð726
50.RivaCE,SinclairSH,GrunwaldJE(1981)Autoregulation of retinal circulation in response to decrease of perfusion pressure. Invest Ophthalmol Vis Sci 21:34Ð38
51. Pakola SJ, Grunwald JE (1993) Effects of oxygen and carbon dioxide on human retinal circulation. Invest Ophthalmol Vis Sci 34:2866Ð2870
52.Riva CE, Grunwald JE, Petrig BL (1983) Reactivity of the human retinal circulation to darkness: a laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 24:737Ð740
53. Feke GT, Zuckerman R, Green GJ, Weiter JJ (1983) Responses of human retinal blood ßow to light and dark. Invest Ophthalmol Vis Sci 24:136Ð141
54. Riva CE, Logean E, Petrig BL, Falsini B (2000) Effet de lÕadaptation ˆ lÕobscuritŽ sur le ßux rŽtinien. Klin Monatsbl Augenheilkd 216:309Ð310
55. Feke GT, Tagawa H, Yoshida A et al (1985) Retinal circulatory changes related to retinopathy progression in insulin-dependent diabetes mellitus. Ophthalmology 92:1517Ð1522
56.Grunwald JE, Riva CE, Sinclair SH, Brucker AJ, Petrig BL (1986) Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol 104:991Ð996
57. Grunwald JE, Riva CE, Baine J, Brucker AJ (1992) Total retinal volumetric blood ßow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 33:356Ð363
58.Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL (1984) Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthal-
mology 91:1447Ð1452
59. Feke GT, Green GL, Goger DG, McMeel JW (1982) Laser Doppler measurements of the effect of panretinal photocoagulation on retinal blood ßow. Ophthalmology 89:757Ð762
60.Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL (1986) Effect of panretinal photocoagulation on retinal blood ßow in proliferative diabetic retinopathy. Ophthalmology 93:590Ð595
61.Grunwald JE, Riva CE, Belcaro GV, Hoffmann U, Bollinger A, Nicolaides AN (1994) Retinal blood
ßow in diabetes Laser Doppler. Med-Orion Publishing Company, London, pp 223Ð247
62. Grunwald JE (1991) Effect of two weeks of timolol maleate treatment on the normal retinal circulation. Invest Ophthalmol Vis Sci 32:39Ð45
63. Grunwald JE, Delehanty J (1992) Effect of topical carteolol on the normal human retinal circulation. Invest Ophthalmol Vis Sci 33:1853Ð1856
64. Grunwald JE, Mathur S, Dupont J (1997) Effects of dorzolamide hydrochloride 2% on the retinal circulation. Acta Ophthalmol Scand 75:236Ð238
65.Bonner RF, Nossal R (1990) Principles of laser Doppler ßowmetry. In: Shepherd AP, …berg PA (eds) Laser-Doppler blood ßowmetry. Kluwer Academic Publishers, Boston, pp 57Ð72
66. Bonner RF, Nossal R, Havlin S, Weiss GH (1987) Model for photon migration in turbid biological media. J Opt Soc Am A 4:423Ð432
7 Laser Doppler Techniques for Ocular Blood Velocity and Flow |
145 |
|
|
67. Petrig BL, Riva CE (1991) Near-infrared retinal laser Doppler velocimetry and ßowmetry: new delivery and detection techniques. Appl Opt 30:2073Ð2078
68. Riva CE, Harino S, Shonat RD, Petrig BL (1991) Flicker evoked increase in optic nerve head blood ßow in anesthetized cats. Neurosci Lett 128:291Ð296
69.Venkataraman ST, Hudson C, Harvey E, Flanagan JG (2005) Impact of simulated light scatter on scanning laser Doppler ßowmetry. Br J Ophthalmol 89: 1192Ð1195
70. Logean E, Geiser MH, Riva CE (2005) Laser Doppler instrument to investigate retinal neural activityinduced changes in optic nerve head blood ßow. Opt Lasers Eng 43:591Ð602
71. Petrig BL, Riva CE (1996) Optic nerve head laser Doppler ßowmetry: principles and computer analysis. In: Kaiser HJ, Flammer J, Hendrickson P (eds) Ocular blood ßow. Karger, Basel, pp 120Ð127
72.Geiser MH, Diermann U, Riva CE (1999) Compact laser Doppler choroidal ßowmeter. J Biomed Opt 4:459Ð464
73.Geiser MH, Moret F, Riva CE (2001) Helmet-mounted Choroidal Laser Doppler ßowmeter. Proc SPIE
4263:91Ð97
74. Koelle JS, Riva CE, Petrig BL, Cranstoun SD (1993) Depth of tissue sampling in the optic nerve head using laser Doppler ßowmetry. Lasers Med Sci 8:49Ð54
75. Riva CE, Hero M, TitzŽ P, Petrig BL (1997) Autoregulation of human optic nerve head blood ßow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol 235: 618Ð626
76. Petrig BL, Riva CE, Hayreh SS (1999) Laser Doppler ßowmetry and optic nerve head blood ßow. Am J Ophthalmol 127:413Ð425
77. Riva CE, Cranstoun SD, Mann RM, Barnes GE (1994) Local choroidal blood ßow in the cat by laser Doppler ßowmetry. Invest Ophthalmol Vis Sci 35:608Ð618
78. Nilsson GE (1990) PerimedÕs LDV Flowmeter. In: Shepherd AP, …berg P• (eds) Laser-Doppler blood ßowmetry. Kluwer Academic Publishers, Boston, pp 57Ð72
79. Sebag J, Delori FC, Feke GT et al (1986) Anterior optic nerve blood ßow decreases in clinical neurogenic optic atrophy. Ophthalmology 93(6):858Ð865
80.Joos KM, Pillunat LE, Knighton KW, Anderson DR, Feuer WJ (1997) Reproducibility of laser Doppler ßowmetry in the human optic nerve head. J Glaucoma 6:212Ð216
81.Grunwald JE, Piltz J, Hariprasad SM, Dupont J, Maguire MG (1999) Optic nerve blood ßow in glaucoma: effect of systemic hypertension. Am J Ophthalmol 127:516Ð522
82.Riva CE, Falsini B, Logean E (2001) Flicker-evoked responses of human optic nerve head blood ßow: luminance versus chromatic modulation. Invest Ophthalmol Vis Sci 42:756Ð762
83. Grunwald JE, Hariprasad SM, Dupont J et al (1998) Foveolar choroidal blood ßow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39:385Ð390
84.Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Maguire MG (2005) Reduced foveolar choroidal blood ßow in eyes with increasing AMD severity.
Invest Ophthalmol Vis Sci 46:1033Ð1038
85. Gugleta K, OrgŸl S, Flammer I, Gherghel D, Flammer J (2002) Reliability of confocal choroidal laser Doppler ßowmetry. Invest Ophthalmol Vis Sci 43:723Ð728
86.Geiser MH, Riva CE, Dorner GT, Diermann U, Luksch A, Schmetterer L (2000) Response of choroidal blood ßow in the foveal region to hyperoxia and hyperoxia-hypercapnia. Curr Eye Res 21:669Ð676
87.Pillunat LE, Anderson DR, Knighton RW, Joos KM, Feuer WJ (1997) Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res 64:737Ð744
88.Movaffaghy A, Chamot SR, Petrig BL, Riva CE (1998) Blood ßow in the human optic nerve head during isometric exercise. Exp Eye Res 67:561Ð568
89. Harris A, Anderson DR, Pillunat L et al (1996) Laser Doppler ßowmetry measurement of changes in human optic nerve head blood ßow in response to blood gas perturbations. J Glaucoma 5:258Ð265
90. Riva CE, Logean E, Falsini B (2005) Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res 24:183Ð215
91. Schmetterer L, Wolzt M, Lexer F et al (1995) The Effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men. Exp Eye Res 61:685Ð690
92. Grunwald JE, Piltz J, Hariprasad SM, Dupont J (1998) Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci 39:2329Ð2336
93.Piltz-Seymour JR (1999) Laser Doppler ßowmetry of the optic nerve head in glaucoma. Surv Ophthalmol 43:S191ÐS198
94.Piltz-Seymour JR, Grunwald JE, Hariprasad SM, Dupont J (2001) Optic nerve blood ßow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol 132:63Ð69
95. Pournaras CJ, Riva CE (2001) Studies of the hemodynamics of the optic head nerve using laser Doppler ßowmetry. J Fr Ophtalmol 24:199Ð205
96. Riva CE, Salgarello T, Logean E, Colotto A, Galan E, Falsini B (2004) Flicker-evoked response measured at the optic disk rim is reduced in ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 45:3662Ð3668
97.Pournaras CJ, Riva CE, Bresson-Dumont H, de Gottrau P, Bechetoille A (2004) Regulation of optic nerve head blood ßow in normal tension glaucoma patients. Eur J Ophthalmol 14:226Ð235
98.Movaffaghy A, Lochhead J, Riva CE et al (2002) Feasibility of LDF measurements of optic nerve head blood ßow in children with cerebral malaria.
Microvasc Res 64:247Ð253
99. Beare NAV, Riva CE, Taylor TE et al (2006) Changes in optic nerve head blood ßow in children with cerebral malaria and acute papilloedema. J Neurol Neurosurg Psychiatry 77:1288Ð1290
146 |
C.E. Riva |
|
|
100.Riva CE, TitzŽ P, Hero M, Movaffaghy A (1997) Choroidal blood ßow during isometric exercises. Invest Ophthalmol Vis Sci 38:2338Ð2343
101.Riva CE, TitzŽ P, Petrig BL (1997) Effect of acute decrease of perfusion pressure on choroidal blood ßow in humans. Invest Ophthalmol Vis Sci 38:1752Ð1760
102.FuchsjŠger-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L (2003) Role of endothelin-1 in choroidal blood ßow regulation during isometric exercice in healthy humans. Invest Ophthalmol Vis Sci 44:728Ð733
103.FuchsjŠger-Mayrl G, Kally B, Georgopoulos M et al (2004) Ocular blood ßow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 45:834Ð839
104.Longo A, Geiser MH, Riva CE (2004) Posture changes and subfoveal choroidal blood ßow. Invest Ophthalmol Vis Sci 45:546Ð551
105.Riva CE, Petrig BL (1995) Choroidal blood ßow by laser Doppler ßowmetry. Opt Eng 34(3):746Ð752
106.Longo A, Geiser MH, Riva CE (2000) Subfoveal choroidal blood ßow in response to light-dark exposure. Invest Ophthalmol Vis Sci 41:2678Ð2683
107.FuchsjŠger-Mayrl G, Polska E, Malec M, Schmetterer L (2001) Unilateral light-dark transitions affect choroidal blood ßow in both eyes. Vision Res 41:2919Ð2924
108.FuchsjŠger-Mayrl G, Malec M, Amoako-Mensah T, Kolodjaschna J, Schmetterer L (2003) Changes in choroidal blood ßow during light/dark transitions are not altered by atropine or propranolol in healthy subjects. Vision Res 43:2185Ð2190
109.Grunwald JE, Hariprasad SM, Dupont J (1998) Effect of aging on foveolar choroidal circulation. Arch Ophthalmol 116:150Ð154
110.Pournaras CJ, Logean E, Riva CE (2004) Choroidal circulatory failure in AMD. Ophthalmic Res 36:201
111.Pournaras CJ, Logean E, Riva CE et al (2006) Regulation of subfoveal choroidal blood ßow in agerelated macular degeneration. Invest Ophthalmol Vis Sci 47:1581Ð1586
